Sort by
Refine Your Search
-
: - Development of programmable control elements for self-amplifying RNA (saRNA) therapeutics. - Regular mentorship meetings with the supervisor - Training in the new technique and workflows relevant
-
: - Participated in grant application writing and if the result deemed successful, may pursued for the patent application - Development of sustainable, safe, regulatory-compliant and high-performing next-generation
-
I Faculty of Science Compensation Range $5,439.00 - $5,910.00 CAD Monthly Posting End Date February 27, 2026 Note: Applications will be accepted until 11:59 PM on the Posting End Date. Job End Date
-
evidence from diverse sources, analyze international survey data, and contribute to the development of a conceptual framework that captures the multi-level and intersectional nature of stigma. Findings from
-
analysis of Surveillance based IPD data ” (ZIKV-IPD-MA-2S) research project. Start date: January 15, 2026 - End date: January 14, 2027 Salary: The annual salary is $70,000 CAD. Location: McGill College 2001
-
work closely with ABIF imaging scientists to advance facility capabilities, support users through training and consultation, and lead innovative technical development projects. More information about the
-
metastatic progression. The Garner lab studies how changes in the bone marrow during myeloid cell development influence their function and contribute to disease progression. Our goal is to identify new
-
are: Create favourable circumstances for the development of a field of research and a community of research on access to justice for OLMCs Produce scientific data for and with the access to justice stakeholders
-
, Sexuality and Social Justice Compensation Range See details below. Posting End Date February 11, 2026 Note: Applications will be accepted until 11:59 PM on the Posting End Date. Job End Date April 30, 2028
-
tissue collection infrastructure, generate foundational single-cell and spatial omics datasets, and develop patient-tissue glioma organoid (PTGO) models to test immunotherapy strategies. The ultimate goal